These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25000669)

  • 1. A randomized controlled clinical trial to assess the desensitizing effect of a stannous fluoride dentifrice.
    He T; Barker ML; Biesbrock A; Sharma N
    Am J Dent; 2014 Apr; 27(2):106-10. PubMed ID: 25000669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical study to assess the effect of a stabilized stannous fluoride dentifrice on hypersensitivity relative to a marketed sodium fluoride/triclosan control.
    He T; Barker ML; Biesbrock AR; Miner M; Qaqish J; Sharma N
    J Clin Dent; 2014; 25(2):13-8. PubMed ID: 25122977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over.
    Schiff T; Mateo LR; Delgado E; Cummins D; Zhang YP; DeVizio W
    J Clin Dent; 2011; 22(4):128-38. PubMed ID: 22403989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative clinical study investigating the efficacy of a test dentifrice containing 8% strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8% arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity.
    Hughes N; Mason S; Jeffery P; Welton H; Tobin M; O'Shea C; Browne M
    J Clin Dent; 2010; 21(2):49-55. PubMed ID: 20669816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three randomized clinical trials to assess the short-term efficacy of anhydrous 0.454% w/w stannous fluoride dentifrices for the relief of dentin hypersensitivity.
    Parkinson CR; Hughes N; Hall C; Whelton H; Gallob J; Mason S
    Am J Dent; 2016 Feb; 29(1):25-32. PubMed ID: 27093773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative clinical study investigating the efficacy of a dentifrice containing 8% strontium acetate and 1040 ppm fluoride in a silica base and a control dentifrice containing 1450 ppm fluoride in a silica base to provide immediate relief of dentin hypersensitivity.
    Mason S; Hughes N; Sufi F; Bannon L; Maggio B; North M; Holt J
    J Clin Dent; 2010; 21(2):42-8. PubMed ID: 20669815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a novel stabilized stannous fluoride and sodium hexametaphosphate dentifrice for dentinal hypersensitivity.
    Schiff T; He T; Sagel L; Baker R
    J Contemp Dent Pract; 2006 May; 7(2):1-8. PubMed ID: 16685289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada.
    Ayad F; Ayad N; Delgado E; Zhang YP; DeVizio W; Cummins D; Mateo LR
    J Clin Dent; 2009; 20(4):115-22. PubMed ID: 19831164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitizing effect of a stabilized stannous fluoride/Sodium hexametaphosphate dentifrice.
    Schiff T; Saletta L; Baker RA; Winston JL; He T
    Compend Contin Educ Dent; 2005 Sep; 26(9 Suppl 1):35-40. PubMed ID: 16999008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of hypersensitivity reduction of a dentifrice containing 0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% NaF and specially-designed silica as compared to a dentifrice containing 0.454% stannous fluoride, sodium hexametaphosphate and zinc lactate and to a dentifrice containing 0.243% NaF on dentin hypersensitivity reduction: an 8-week study.
    Chaknis P; Panagakos FS; DeVizio W; Sowinski J; Petrone D; Proskin H
    Am J Dent; 2011 Jul; 24 Spec No A():14A-20A. PubMed ID: 22216653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices.
    Sowinski JA; Bonta Y; Battista GW; Petrone D; DeVizio W; Petrone M; Proskin HM
    Am J Dent; 2000 Jun; 13(3):116-20. PubMed ID: 11763945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of dentin hypersensitivity with the Jay Sensitivity Sensor Probe and the Yeaple probe to compare relief from dentin hypersensitivity by dentifrices.
    Kakar A; Kakar K
    Am J Dent; 2013 May; 26 Spec No B():21B-28B. PubMed ID: 24156205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitizing efficacy of a new dentifrice containing 5.0% potassium nitrate and 0.454% stannous fluoride.
    Schiff T; Bonta Y; Proskin HM; DeVizio W; Petrone M; Volpe AR
    Am J Dent; 2000 Jun; 13(3):111-5. PubMed ID: 11763944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of dentifrices for clinical relief from dentin hypersensitivity using the Jay Sensitivity Sensor Probe.
    Hegde S; Rao BH; Kakar RC; Kakar A
    Am J Dent; 2013 May; 26 Spec No B():29B-36B. PubMed ID: 24156206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative investigation of the desensitizing efficacy of a new dentifrice containing 5.5% potassium citrate: an eight-week clinical study.
    Hu D; Zhang YP; Chaknis P; Petrone ME; Volpe AR; DeVizio W
    J Clin Dent; 2004; 15(1):6-10. PubMed ID: 15218709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of an experimental dentifrice containing 0.454% w/w stannous fluoride in providing relief from the pain of dentin hypersensitivity: an 8-week clinical study.
    Parkinson C; Hughes N; Jeffery P; Jain R; Kennedy L; Qaqish J; Gallob JT; Mason S
    Am J Dent; 2013 Mar; 26 Spec No A():25A-31A. PubMed ID: 23833916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinical efficacy of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm fluoride to a commercially available sensitive toothpaste containing 2% potassium ion on dentin hypersensitivity: a randomized clinical trial.
    Kakar A; Kakar K; Sreenivasan PK; DeVizio W; Kohli R
    J Clin Dent; 2012; 23(2):40-7. PubMed ID: 22779216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical efficacy of three toothpastes in reducing dentin hypersensitivity.
    Li Y; Lee S; Zhang YP; Delgado E; DeVizio W; Mateo LR
    J Clin Dent; 2011; 22(4):113-20. PubMed ID: 22403987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of a new dentifrice with 8% arginine and calcium carbonate on dentin hypersensitivity in an Indian population using a new measuring device: the Jay Sensitivity Sensor Probe.
    Kakar A; Dibart S; Kakar K
    Am J Dent; 2013 May; 26 Spec No B():13B-20B. PubMed ID: 24156204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark commercial desensitizing toothpaste containing 2% potassium ion: an eight-week clinical study in Rome, Italy.
    Docimo R; Montesani L; Maturo P; Costacurta M; Bartolino M; Zhang YP; DeVizio W; Delgado E; Cummins D; Dibart S; Mateo LR
    J Clin Dent; 2009; 20(4):137-43. PubMed ID: 19831167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.